<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Combinatorial Chemistry &amp; High Throughput Screening</journal-id><journal-title-group><journal-title xml:lang="en">Combinatorial Chemistry &amp; High Throughput Screening</journal-title><trans-title-group xml:lang="ru"><trans-title>Combinatorial Chemistry &amp; High Throughput Screening</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1386-2073</issn><issn publication-format="electronic">1875-5402</issn><publisher><publisher-name xml:lang="en">Bentham Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">644516</article-id><article-id pub-id-type="doi">10.2174/0113862073259884231024111447</article-id><article-categories><subj-group subj-group-type="toc-heading"><subject>Chemistry</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Zang Siwei Qingfei Mixture Alleviates Inflammatory Response to Attenuate Acute Lung Injury by the ACE2/NF-κB Signaling Pathway in Mice</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lei</surname><given-names>Si</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Shangjie</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff id="aff1"><institution>Department of General Medicine, Second Xiangya Hospital of Central South University</institution></aff><aff id="aff2"><institution>Department of Respiratory Medicine, Second Xiangya Hospital of Central South University</institution></aff><pub-date date-type="pub" iso-8601-date="2024-10-01" publication-format="electronic"><day>01</day><month>10</month><year>2024</year></pub-date><volume>27</volume><issue>19</issue><issue-title xml:lang="ru"/><fpage>2871</fpage><lpage>2884</lpage><history><date date-type="received" iso-8601-date="2025-01-07"><day>07</day><month>01</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Bentham Science Publishers</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Bentham Science Publishers</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://rjpbr.com/1386-2073/article/view/644516">https://rjpbr.com/1386-2073/article/view/644516</self-uri><abstract xml:lang="en"><p id="idm46041443706496">Background:Acute lung injury (ALI) is a serious lung disease characterized by acute and severe inflammation. Upregulation of ACE2 and inhibition of the NF-κB signaling pathway attenuate LPS-induced ALI.</p><p id="idm46041443710496">Objective:To explore whether Zang Siwei Qingfei Mixture inhibits the development of ALI through the ACE2/NF-κB signaling pathway.</p><p id="idm46041443714464">Methods:Alveolar type II epithelial cells (AEC II) were identified by immunofluorescence staining and flow cytometry. C57BL/6J mice were treated with LPS to establish an ALI model. Cell viability was assessed using CCK8 assays. The levels of ACE, ACE2, p-p38/p38, p- ERK1/2/ERK1/2, p-JNK/JNK, p-IκBα/IκB-α, p-NF-κBp65 were analyzed by Western blotting. ELISA was applied to detect the levels of TNF-a, IL-6, AGT, and Ang1-7. HE staining was used to observe lung injury. The mRNA expression of ACE, ACE2, and Mas was measured by RT-qPCR.</p><p id="idm46041443719520">Results:AEC II cells were successfully isolated. Treatment with the Zang Siwei Qingfei Mixture resulted in a decrease in ACE, p-p38/p38, p-ERK1/2/ERK1/2, p-JNK/JNK, p-IκBα/IκB-α, p-NF-κBp65 levels, while increasing ACE2 levels. Zang Siwei Qingfei mixture also led to a reduction in TNF-α, IL6, and AGT levels, while increasing Ang1-7 level. Histological analysis showed that Zang Siwei Qingfei Mixture treatment improved the alveolar structure of ALI mice and reduced inflammatory infiltration. The pretreatment with MLN-4760, an ACE2 inhibitor, resulted in opposite effects compared to Zang Siwei Qingfei Mixture treatment.</p><p id="idm46041443728896">Conclusion:Zang Siwei Qingfei mixture attenuates ALI by regulating the ACE2/NF-κB signaling pathway in mice. This study provides a theoretical foundation for the development of improved ALI treatments.</p></abstract><kwd-group xml:lang="en"><kwd>Zang siwei qingfei mixture</kwd><kwd>ACE2/NF-κB</kwd><kwd>inflammatory reaction</kwd><kwd>acute lung injury</kwd><kwd>alveolar type II epithelial cells (AEC II)</kwd><kwd>angiotensin-converting enzyme (ACE).</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Li, Y.; Cao, Y.; Xiao, J.; Shang, J.; Tan, Q.; Ping, F.; Huang, W.; Wu, F.; Zhang, H.; Zhang, X. Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia/reperfusion-induced acute lung injury. Cell Death Differ., 2020, 27(9), 2635-2650. doi: 10.1038/s41418-020-0528-x PMID: 32203170</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Hong, H.; Lou, S.; Zheng, F.; Gao, H.; Wang, N.; Tian, S.; Huang, G.; Zhao, H. Hydnocarpin D attenuates lipopolysaccharide-induced acute lung injury via MAPK/NF-κB and Keap1/Nrf2/HO-1 pathway. Phytomedicine, 2022, 101, 154143. doi: 10.1016/j.phymed.2022.154143 PMID: 35537248</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Laskin, D.L.; Malaviya, R.; Laskin, J.D. Role of macrophages in acute lung injury and chronic fibrosis induced by pulmonary toxicants. Toxicol. Sci., 2019, 168(2), 287-301. doi: 10.1093/toxsci/kfy309 PMID: 30590802</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Chang, Y.W.; Tseng, C.P.; Lee, C.H.; Hwang, T.L.; Chen, Y.L.; Su, M.T.; Chong, K.Y.; Lan, Y.W.; Wu, C.C.; Chen, K.J.; Lu, F.H.; Liao, H.R.; Hsueh, C.; Hsieh, P.W. β-Nitrostyrene derivatives attenuate LPS-mediated acute lung injury via the inhibition of neutrophil-platelet interactions and NET release. Am. J. Physiol. Lung Cell. Mol. Physiol., 2018, 314(4), L654-L669. doi: 10.1152/ajplung.00501.2016 PMID: 29351433</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Jansing, J.C.; Fiedler, J.; Pich, A.; Viereck, J.; Thum, T.; Mühlfeld, C.; Brandenberger, C. miR-21-KO Alleviates alveolar structural remodeling and inflammatory signaling in acute lung injury. Int. J. Mol. Sci., 2020, 21(3), 822. doi: 10.3390/ijms21030822 PMID: 32012801</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Sapoznikov, A.; Gal, Y.; Falach, R.; Sagi, I.; Ehrlich, S.; Lerer, E.; Makovitzki, A.; Aloshin, A.; Kronman, C.; Sabo, T. Early disruption of the alveolar-capillary barrier in a ricin-induced ARDS mouse model: Neutrophil-dependent and -independent impairment of junction proteins. Am. J. Physiol. Lung Cell. Mol. Physiol., 2019, 316(1), L255-L268. doi: 10.1152/ajplung.00300.2018 PMID: 30382767</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Zhu, P.; Zhang, W.; Feng, F.; Qin, L.; Ji, W.; Li, D.; Liang, R.; Zhang, Y.; Wang, Y.; Li, M.; Wu, W.; Jin, Y.; Duan, G. Role of angiotensin-converting enzyme 2 in fine particulate matter-induced acute lung injury. Sci. Total Environ., 2022, 825, 153964. doi: 10.1016/j.scitotenv.2022.153964 PMID: 35182631</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Hrenak, J.; Simko, F. Renin-angiotensin system: An important player in the pathogenesis of acute respiratory distress syndrome. Int. J. Mol. Sci., 2020, 21(21), 8038. doi: 10.3390/ijms21218038 PMID: 33126657</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Chen, Q.; Liu, J.; Wang, W.; Liu, S.; Yang, X.; Chen, M.; Cheng, L.; Lu, J.; Guo, T.; Huang, F. Sini decoction ameliorates sepsis-induced acute lung injury via regulating ACE2-Ang (1-7)-Mas axis and inhibiting the MAPK signaling pathway. Biomed. Pharmacother., 2019, 115, 108971. doi: 10.1016/j.biopha.2019.108971 PMID: 31102910</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Zhou, Q.; He, D.X.; Deng, Y.L.; Wang, C.L.; Zhang, L.L.; Jiang, F.M.; Irakoze, L.; Liang, Z.A. MiR-124-3p targeting PDE4B attenuates LPS-induced ALI through the TLR4/NF-κB signaling pathway. Int. Immunopharmacol., 2022, 105, 108540. doi: 10.1016/j.intimp.2022.108540 PMID: 35063752</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Han, S.; Yuan, R.; Cui, Y.; He, J.; Wang, Q.Q.; Zhuo, Y.; Yang, S.; Gao, H.; Hederasaponin, C. Hederasaponin C alleviates lipopolysaccharide-induced acute lung injury in vivo and in vitro through the PIP2/NF-κB/NLRP3 signaling pathway. Front. Immunol., 2022, 13, 846384. doi: 10.3389/fimmu.2022.846384 PMID: 35281058</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Chen, Y.; Qu, L.; Li, Y.; Chen, C.; He, W.; Shen, L.; Zhang, R. Glycyrrhizic acid alleviates lipopolysaccharide (LPS)-induced acute lung injury by regulating angiotensin-converting enzyme-2 (ACE2) and caveolin-1 signaling pathway. Inflammation, 2022, 45(1), 253-266. doi: 10.1007/s10753-021-01542-8 PMID: 34427852</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Yan, L.S.; Cui, S.; Cheng, B.C.Y.; Yin, X.B.; Wang, Y.W.; Qiu, X.Y.; Nima, C.R.; Zhang, Y.; Zhang, S.F. Sichen formula ameliorates lipopolysaccharide-induced acute lung injury via blocking the TLR4 signaling pathways. Drug Des. Devel. Ther., 2023, 17, 297-312. doi: 10.2147/DDDT.S372981 PMID: 36756190</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Wang, C.; Ren, L.; Chen, S.; Zheng, H.; Yang, Y.; Gu, T.; Li, Y.; Wang, C. Longdan Xiegan Tang attenuates liver injury and hepatic insulin resistance by regulating the angiotensin-converting enzyme 2/Ang (17)/Mas axis-mediated anti-inflammatory pathway in rats. J. Ethnopharmacol., 2021, 274, 114072. doi: 10.1016/j.jep.2021.114072 PMID: 33781876</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Notarte, K.I.R.; Quimque, M.T.J.; Macaranas, I.T.; Khan, A.; Pastrana, A.M.; Villaflores, O.B.; Arturo, H.C.P.; Pilapil, D.Y.H., IV; Tan, S.M.M.; Wei, D.Q.; Wenzel-Storjohann, A.; Tasdemir, D.; Yen, C.H.; Ji, S.Y.; Kim, G.Y.; Choi, Y.H.; Macabeo, A.P.G. Attenuation of Lipopolysaccharide-Induced Inflammatory Responses through Inhibition of the NF-κB Pathway and the Increased NRF2 Level by a Flavonol-Enriched n -Butanol Fraction from Uvaria alba. ACS Omega, 2023, 8(6), 5377-5392. doi: 10.1021/acsomega.2c06451 PMID: 36816691</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>He, Y.Q.; Zhou, C.C.; Yu, L.Y.; Wang, L.; Deng, J.; Tao, Y.L.; Zhang, F.; Chen, W.S. Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms. Pharmacol. Res., 2021, 163, 105224. doi: 10.1016/j.phrs.2020.105224 PMID: 33007416</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Jiang, R.; Luo, S.; Zhang, M.; Lan, Q.; Zhao, X.; Wang, W.; Zhuo, S.; Wang, X.; Jiang, X. Jianpiyiqi decoction inhibits proliferation and invasion by suppressing the Caspase-1/IRAKs/NF-KB signalling pathway in hepatoma Huh-7 cells. Eur. J. Integr. Med., 2023, 58, 102230. doi: 10.1016/j.eujim.2023.102230</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Donati, Y.; Blaskovic, S.; Ruchonnet-Métrailler, I.; Lascano Maillard, J.; Barazzone-Argiroffo, C. Simultaneous isolation of endothelial and alveolar epithelial type I and type II cells during mouse lung development in the absence of a transgenic reporter. Am. J. Physiol. Lung Cell. Mol. Physiol., 2020, 318(4), L619-L630. doi: 10.1152/ajplung.00227.2019 PMID: 32022591</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Chen, Q.; Liu, Y. Isolation and culture of mouse alveolar type II cells to study type II to type I cell differentiation. STAR Protoc., 2021, 2(1), 100241.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Ma, Q.; Li, R.; Pan, W.; Huang, W.; Liu, B.; Xie, Y.; Wang, Z.; Li, C.; Jiang, H.; Huang, J.; Shi, Y.; Dai, J.; Zheng, K.; Li, X.; Hui, M.; Fu, L.; Yang, Z. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway. Phytomedicine, 2020, 78, 153296.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Saravanan, R.; Ramachandran, V. Modulating efficacy of Rebaudioside A, a diterpenoid on antioxidant and circulatory lipids in experimental diabetic rats. Environ. Toxicol. Pharmacol., 2013, 36(2), 472-483. doi: 10.1016/j.etap.2013.05.009 PMID: 23792234</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Wang, Y.; Li, L.; Wang, Y.; Zhu, X.; Jiang, M.; Song, E.; Song, Y. New application of the commercial sweetener rebaudioside a as a hepatoprotective candidate: Induction of the Nrf2 signaling pathway. Eur. J. Pharmacol., 2018, 822, 128-137. doi: 10.1016/j.ejphar.2018.01.020 PMID: 29355553</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Wang, J.; Yang, H.; Li, Q.; Wu, X.; Di, G.; Fan, J.; Wei, D.; Guo, C. Novel nanomicelles based on rebaudioside A: A potential nanoplatform for oral delivery of honokiol with enhanced oral bioavailability and antitumor activity. Int. J. Pharm., 2020, 590, 119899. doi: 10.1016/j.ijpharm.2020.119899 PMID: 32971177</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Kurek, J.M.; Król, E.; Krejpcio, Z. Steviol glycosides supplementation affects lipid metabolism in high-fat fed stz-induced diabetic rats. Nutrients, 2020, 13(1), 112. doi: 10.3390/nu13010112 PMID: 33396905</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Wang, Q.P.; Browman, D.; Herzog, H.; Neely, G.G.; Neely, G.G. Non-nutritive sweeteners possess a bacteriostatic effect and alter gut microbiota in mice. PLoS One, 2018, 13(7), e0199080. doi: 10.1371/journal.pone.0199080 PMID: 29975731</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Tian, X.; Liu, Y.; Liu, X.; Gao, S.; Sun, X. Glycyrrhizic acid ammonium salt alleviates Concanavalin A-induced immunological liver injury in mice through the regulation of the balance of immune cells and the inhibition of hepatocyte apoptosis. Biomed. Pharmacother., 2019, 120, 109481. doi: 10.1016/j.biopha.2019.109481 PMID: 31586906</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Barone, A.; Cristiano, M.C.; Cilurzo, F.; Locatelli, M.; Iannotta, D.; Di Marzio, L.; Celia, C.; Paolino, D. Ammonium glycyrrhizate skin delivery from ultradeformable liposomes: A novel use as an anti-inflammatory agent in topical drug delivery. Colloids Surf. B Biointerfaces, 2020, 193, 111152. doi: 10.1016/j.colsurfb.2020.111152 PMID: 32535351</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Ciarlo, L.; Marzoli, F.; Minosi, P.; Matarrese, P.; Pieretti, S. Ammonium glycyrrhizinate prevents apoptosis and mitochondrial dysfunction induced by high glucose in SH-SY5Y cell line and counteracts neuropathic pain in streptozotocin-induced diabetic mice. Biomedicines, 2021, 9(6), 608. doi: 10.3390/biomedicines9060608 PMID: 34073550</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Shin, J.S. Im, H.T.; Lee, K.T. Saikosaponin B2 suppresses inflammatory responses through IKK/IκBα/NF-κB Signaling inactivation in LPS-induced raw 264.7 macrophages. Inflammation, 2019, 42(1), 342-353. doi: 10.1007/s10753-018-0898-0 PMID: 30251218</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Zhao, Y.; Feng, L.; Liu, L.; Zhao, R. Saikosaponin b2 enhances the hepatotargeting effect of anticancer drugs through inhibition of multidrug resistance-associated drug transporters. Life Sci., 2019, 231, 116557. doi: 10.1016/j.lfs.2019.116557 PMID: 31194994</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Lin, L.T.; Chung, C.Y.; Hsu, W.C.; Chang, S.P.; Hung, T.C.; Shields, J.; Russell, R.S.; Lin, C.C.; Li, C.F.; Yen, M.H.; Tyrrell, D.L.J.; Lin, C.C.; Richardson, C.D. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry. J. Hepatol., 2015, 62(3), 541-548. doi: 10.1016/j.jhep.2014.10.040 PMID: 25450204</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Ren, D.; Luo, J.; Li, Y.; Zhang, J.; Yang, J.; Liu, J.; Zhang, X.; Cheng, N.; Xin, H. Saikosaponin B2 attenuates kidney fibrosis via inhibiting the Hedgehog Pathway. Phytomedicine, 2020, 67, 153163. doi: 10.1016/j.phymed.2019.153163 PMID: 31901891</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>You, M.; Fu, J.; Lv, X.; Wang, L.; Wang, H.; Li, R. Saikosaponin b2 inhibits tumor angiogenesis in liver cancer via down regulation of VEGF/ERK/HIF 1α signaling. Oncol. Rep., 2023, 50(1), 136. doi: 10.3892/or.2023.8573</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>X, W. Saikosaponin B2 ameliorates depression-induced microglia activation by inhibiting ferroptosis-mediated neuroinflammation and ER stress. J. Ethnopharmacol., 2023, 316, 116729.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Nan, J. Eleutheroside E from pre-treatment of Acanthopanax senticosus (Rupr.etMaxim.) Harms ameliorates high-altitude-induced heart injury by regulating NLRP3 inflammasome-mediated pyroptosis via NLRP3/caspase-1 pathway. Int. Immunopharmacol., 2023, 121, 110423.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Huijuan, L. The protective effect of Eleutheroside E against the mechanical barrier dysfunction triggered by lipopolysaccharide in IPEC-J2 cells. Res. Vet. Sci., 2023, 154, 1-7.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Yao, Y.; Liao, C.; Qiu, H.; Liang, L.; Zheng, W.; Wu, L.; Meng, F. Effect of eleutheroside E on an MPTP-induced parkinsons disease cell model and its mechanism. Molecules, 2023, 28(9), 3820. doi: 10.3390/molecules28093820 PMID: 37175230</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Liu, Z.; Gao, W.; Xu, Y. Eleutheroside E alleviates cerebral ischemia-reperfusion injury in a 5-hydroxytryptamine receptor 2C (Htr2c)-dependent manner in rats. Bioengineered, 2022, 13(5), 11718-11731. doi: 10.1080/21655979.2022.2071009 PMID: 35502892</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Mengyao, L. Eleutheroside E reduces intestinal fat accumulation in Caenorhabditis elegans through neuroendocrine signals. J. Sci. Food Agric., 2022, 102(12), 5219-5228.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Yipin, C. Eleutheroside E functions as anti-cervical cancer drug by inhibiting the phosphatidylinositol 3-kinase pathway and reprogramming the metabolic responses. J. Pharm. Pharmacol., 2022, 74(9), 1251-1260.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Song, C.; Duan, F.; Ju, T.; Qin, Y.; Zeng, D.; Shan, S.; Shi, Y.; Zhang, Y.; Lu, W. Eleutheroside E supplementation prevents radiation-induced cognitive impairment and activates PKA signaling via gut microbiota. Commun. Biol., 2022, 5(1), 680. doi: 10.1038/s42003-022-03602-7 PMID: 35804021</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Ana Beatriz Farias, D.S. Effects in vitro and in vivo of hesperidin administration in an experimental model of acute lung inflammation. Free Radic. Biol. Med., 2022, 180, 253-262.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Yuan, X.; Zhu, J.; Kang, Q.; He, X.; Guo, D. Protective effect of hesperidin against sepsis-induced lung injury by inducing the heat-stable protein 70 (Hsp70)/toll-like receptor 4 (TLR4)/myeloid differentiation primary response 88 (MyD88) pathway. Med. Sci. Monit., 2019, 25, 107-114. doi: 10.12659/MSM.912490 PMID: 30608918</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Liu, X.; Yu, D.; Chen, M.; Sun, T.; Li, G.; Huang, W.; Nie, H.; Wang, C.; Zhang, Y.; Gong, Q.; Ren, B. Hesperidin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting HMGB1 release. Int. Immunopharmacol., 2015, 25(2), 370-376. doi: 10.1016/j.intimp.2015.02.022 PMID: 25724384</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Di, H. Hesperidin inhibits lung fibroblast senescence via IL-6/STAT3 signaling pathway to suppress pulmonary fibrosis. Phytomedicine, 2023, 112, 154680.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Park, J.H.; Ku, H.J.; Park, J.W. Hesperetin mitigates acrolein-induced apoptosis in lung cells in vitro and in vivo. Redox Rep., 2018, 23(1), 188-193. doi: 10.1080/13510002.2018.1535640 PMID: 30325253</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Ruihong, Y. Neohesperidin dihydrochalbazone protects against septic acute kidney injury in mice. Phytomedicine, 2023, 110, 154623.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Zhang, J.; Hui, Y.; Liu, F.; Yang, Q.; Lu, Y.; Chang, Y.; Liu, Q.; Ding, Y. Neohesperidin Protects Angiotensin II-Induced Hypertension and Vascular Remodeling. Front. Pharmacol., 2022, 13, 890202. doi: 10.3389/fphar.2022.890202 PMID: 35677431</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Guo, J.; Fang, Y.; Jiang, F.; Li, L.; Zhou, H.; Xu, X.; Ning, W. Neohesperidin inhibits TGF-β1/Smad3 signaling and alleviates bleomycin-induced pulmonary fibrosis in mice. Eur. J. Pharmacol., 2019, 864, 172712. doi: 10.1016/j.ejphar.2019.172712 PMID: 31586469</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Shubin, W. Neohesperidin induces cell cycle arrest, apoptosis, and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells. Am. J. Chin. Med., 2021, 49(5), 1251-1274.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Ndivhuwo, M. Rutin ameliorates inflammation and improves metabolic function: A comprehensive analysis of scientific literature. Pharmacol. Res., 2022, 178, 106163.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Yeh, C.H.; Yang, J.J.; Yang, M.L.; Li, Y.C.; Kuan, Y.H. Rutin decreases lipopolysaccharide-induced acute lung injury via inhibition of oxidative stress and the MAPKNF-κB pathway. Free Radic. Biol. Med., 2014, 69, 249-257. doi: 10.1016/j.freeradbiomed.2014.01.028 PMID: 24486341</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Chen, W.Y.; Huang, Y.C.; Yang, M.L.; Lee, C.Y.; Chen, C.J.; Yeh, C.H.; Pan, P.H.; Horng, C.T.; Kuo, W.H.; Kuan, Y.H. Protective effect of rutin on LPS-induced acute lung injury via down-regulation of MIP-2 expression and MMP-9 activation through inhibition of Akt phosphorylation. Int. Immunopharmacol., 2014, 22(2), 409-413. doi: 10.1016/j.intimp.2014.07.026 PMID: 25091621</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Huang, Y.C.; Horng, C.T.; Chen, S.T.; Lee, S.S.; Yang, M.L.; Lee, C.Y.; Kuo, W.H.; Yeh, C.H.; Kuan, Y.H. Rutin improves endotoxin-induced acute lung injury via inhibition of iNOS and VCAM-1 expression. Environ. Toxicol., 2016, 31(2), 185-191. doi: 10.1002/tox.22033 PMID: 25080890</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Ganeshpurkar, A.; Saluja, A.K. Protective effect of rutin on humoral and cell mediated immunity in rat model. Chem. Biol. Interact., 2017, 273, 154-159. doi: 10.1016/j.cbi.2017.06.006 PMID: 28606468</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Bai, L.; Li, A.; Gong, C.; Ning, X.; Wang, Z. Protective effect of rutin against bleomycin induced lung fibrosis: Involvement of TGF ‐β1/α‐SMA/Col I and III pathway. Biofactors, 2020, 46(4), 637-644. doi: 10.1002/biof.1629 PMID: 32233122</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Kim, C.; Sim, H.; Bae, J.S. Benzoylpaeoniflorin activates anti-inflammatory mechanisms to mitigate sepsis in cell-culture and mouse sepsis models. Int. J. Mol. Sci., 2022, 23(21), 13130. doi: 10.3390/ijms232113130 PMID: 36361915</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Wan-Chao, Z. Anti-anaphylactic potential of benzoylpaeoniflorin through inhibiting HDC and MAPKs from Paeonia lactiflora. Chin. J. Nat. Med., 2021, 19(11), 825-835.</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Zhuang, H.; Lv, Q.; Zhong, C.; Cui, Y.; He, L.; Zhang, C.; Yu, J. Tiliroside ameliorates ulcerative colitis by restoring the M1/M2 macrophage balance via the HIF-1α/glycolysis pathway. Front. Immunol., 2021, 12, 649463. doi: 10.3389/fimmu.2021.649463</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Mengjie, X. Anti-influenza properties of tiliroside isolated from Hibiscus mutabilis L. J. Ethnopharmacol., 2023, 303, 115918.</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Han, R.; Yang, H.; Ling, C.; Lu, L. Tiliroside suppresses triple-negative breast cancer as a multifunctional CAXII inhibitor. Cancer Cell Int., 2022, 22(1), 368. doi: 10.1186/s12935-022-02786-6 PMID: 36424626</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Zhang, C.; Jiang, Y.; Liu, J.; Jin, M.; Qin, N.; Chen, Y.; Niu, W.; Duan, H. AMPK/AS160 mediates tiliroside derivatives-stimulated GLUT4 translocation in muscle cells. Drug Des. Devel. Ther., 2018, 12, 1581-1587. doi: 10.2147/DDDT.S164441 PMID: 29910604</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Velagapudi, R.; El-Bakoush, A.; Olajide, O.A. Activation of Nrf2 pathway contributes to neuroprotection by the dietary flavonoid tiliroside. Mol. Neurobiol., 2018, 55(10), 8103-8123. doi: 10.1007/s12035-018-0975-2 PMID: 29508282</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Ruaro, B.; Salton, F.; Braga, L.; Wade, B.; Confalonieri, P.; Volpe, M.C.; Baratella, E.; Maiocchi, S.; Confalonieri, M. The history and mystery of alveolar epithelial type II cells: Focus on their physiologic and pathologic role in lung. Int. J. Mol. Sci., 2021, 22(5), 2566. doi: 10.3390/ijms22052566 PMID: 33806395</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Nureki, S.I.; Tomer, Y.; Venosa, A.; Katzen, J.; Russo, S.J.; Jamil, S.; Barrett, M.; Nguyen, V.; Kopp, M.; Mulugeta, S.; Beers, M.F. Expression of mutant Sftpc in murine alveolar epithelia drives spontaneous lung fibrosis. J. Clin. Invest., 2018, 128(9), 4008-4024. doi: 10.1172/JCI99287 PMID: 29920187</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Xu, Q.; Xu, J.; Wu, Y. Regulation of inflammation and apoptosis by GPR43 via JNK/ELK1 in acute lung injury. Inflamm. Res., 2022, 71(5-6), 603-614. doi: 10.1007/s00011-022-01556-4 PMID: 35306578</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Yue, Q.; Zhang, W.; Lin, S.; Zheng, T.; Hou, Y.; Zhang, Y.; Li, Z.; Wang, K.; Yue, L.; Abay, B.; Li, M.; Fan, L. Ejiao ameliorates lipopolysaccharide-induced pulmonary inflammation via inhibition of NFκB regulating NLRP3 inflammasome and mitochondrial ROS. Biomed. Pharmacother., 2022, 152, 113275. doi: 10.1016/j.biopha.2022.113275 PMID: 35714510</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Ma, Q.; Li, R.; Pan, W.; Huang, W.; Liu, B.; Xie, Y.; Wang, Z.; Li, C.; Jiang, H.; Huang, J.; Shi, Y.; Dai, J.; Zheng, K.; Li, X.; Hui, M.; Fu, L.; Yang, Z. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway. Phytomedicine, 2020, 78, 153296. doi: 10.1016/j.phymed.2020.153296 PMID: 32890913</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>Zhang, C.; Wang, X.; Wang, C.; He, C.; Ma, Q.; Li, J.; Wang, W.; Xu, Y.T.; Wang, T. Qingwenzhike prescription alleviates acute lung injury induced by LPS via inhibiting TLR4/NF-KB pathway and nlrp3 inflammasome activation. Front. Pharmacol., 2021, 12, 790072. doi: 10.3389/fphar.2021.790072 PMID: 35002723</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>He, Y.Q.; Zhou, C.C.; Deng, J.L.; Wang, L.; Chen, W.S. Tanreqing Inhibits LPS-Induced Acute Lung Injury in vivo and in vitro Through Downregulating sting Signaling Pathway. Front. Pharmacol., 2021, 12, 746964. doi: 10.3389/fphar.2021.746964 PMID: 34721036</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>Liu, J.; Chen, Q.; Liu, S.; Yang, X.; Zhang, Y.; Huang, F. Sini decoction alleviates E. coli induced acute lung injury in mice via equilibrating ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis. Life Sci., 2018, 208, 139-148. doi: 10.1016/j.lfs.2018.07.013 PMID: 29990483</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>Huang, H.; Wang, J.; Liu, Z.; Gao, F. The angiotensin-converting enzyme 2/angiotensin (17)/mas axis protects against pyroptosis in LPS-induced lung injury by inhibiting NLRP3 activation. Arch. Biochem. Biophys., 2020, 693, 108562. doi: 10.1016/j.abb.2020.108562 PMID: 32866470</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>Xing, J.; Yu, Z.; Zhang, X.; Li, W.; Gao, D.; Wang, J.; Ma, X.; Nie, X.; Wang, W. Epicatechin alleviates inflammation in lipopolysaccharide-induced acute lung injury in mice by inhibiting the p38 MAPK signaling pathway. Int. Immunopharmacol., 2019, 66, 146-153. doi: 10.1016/j.intimp.2018.11.016 PMID: 30453148</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation>Su, V.Y.F.; Yang, K.Y.; Chiou, S.H.; Chen, N.J.; Mo, M.H.; Lin, C.S.; Wang, C.T. Induced pluripotent stem cells regulate triggering receptor expressed on myeloid cell-1 expression and the p38 mitogen-activated protein kinase pathway in endotoxin-induced acute lung injury. Stem Cells, 2019, 37(5), 631-639. doi: 10.1002/stem.2980 PMID: 30681755</mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation>Li, T.; Wu, Y.N.; Wang, H.; Ma, J.Y.; Zhai, S.S.; Duan, J. Dapk1 improves inflammation, oxidative stress and autophagy in LPS-induced acute lung injury via p38MAPK/NF-κB signaling pathway. Mol. Immunol., 2020, 120, 13-22. doi: 10.1016/j.molimm.2020.01.014 PMID: 32045770</mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation>Cong, Z.; Yang, C.; Zeng, Z.; Wu, C.; Zhao, F.; Shen, Z.; Xiao, H.; Zhu, X. α1-adrenoceptor stimulation ameliorates lipopolysaccharide-induced lung injury by inhibiting alveolar macrophage inflammatory responses through NF-κB and ERK1/2 pathway in ARDS. Front. Immunol., 2023, 13, 1090773. doi: 10.3389/fimmu.2022.1090773 PMID: 36685596</mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation>Yazicioglu, T.; Mühlfeld, C.; Autilio, C.; Huang, C.K.; Bär, C.; Dittrich-Breiholz, O.; Thum, T.; Pérez-Gil, J.; Schmiedl, A.; Brandenberger, C. Aging impairs alveolar epithelial type II cell function in acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol., 2020, 319(5), L755-L769. doi: 10.1152/ajplung.00093.2020 PMID: 32877222</mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation>Paris, A.J.; Hayer, K.E.; Oved, J.H.; Avgousti, D.C.; Toulmin, S.A.; Zepp, J.A.; Zacharias, W.J.; Katzen, J.B.; Basil, M.C.; Kremp, M.M.; Slamowitz, A.R.; Jayachandran, S.; Sivakumar, A.; Dai, N.; Wang, P.; Frank, D.B.; Eisenlohr, L.C.; Cantu, E., III; Beers, M.F.; Weitzman, M.D.; Morrisey, E.E.; Worthen, G.S. STAT3BDNFTrkB signalling promotes alveolar epithelial regeneration after lung injury. Nat. Cell Biol., 2020, 22(10), 1197-1210. doi: 10.1038/s41556-020-0569-x PMID: 32989251</mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation>Penkala, I.J.; Liberti, D.C.; Pankin, J.; Sivakumar, A.; Kremp, M.M.; Jayachandran, S.; Katzen, J.; Leach, J.P.; Windmueller, R.; Stolz, K.; Morley, M.P.; Babu, A.; Zhou, S.; Frank, D.B.; Morrisey, E.E. Age-dependent alveolar epithelial plasticity orchestrates lung homeostasis and regeneration. Cell Stem Cell, 2021, 28(10), 1775-1789. doi: 10.1016/j.stem.2021.04.026</mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation>Liberti, D.C.; Kremp, M.M.; Liberti, W.A., III; Penkala, I.J.; Li, S.; Zhou, S.; Morrisey, E.E. Alveolar epithelial cell fate is maintained in a spatially restricted manner to promote lung regeneration after acute injury. Cell Rep., 2021, 35(6), 109092. doi: 10.1016/j.celrep.2021.109092 PMID: 33979629</mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation>Zhang, T.; Li, M.; Zhao, S.; Zhou, M.; Liao, H.; Wu, H.; Mo, X.; Wang, H.; Guo, C.; Zhang, H.; Yang, N.; Huang, Y. CaMK4 promotes acute lung injury through nlrp3 inflammasome activation in type II alveolar epithelial cell. Front. Immunol., 2022, 13, 890710. doi: 10.3389/fimmu.2022.890710 PMID: 35734175</mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation>Chen, F.; Xie, L.; Kang, R.; Deng, R.; Xi, Z.; Sun, D.; Zhu, J.; Wang, L. Gentiopicroside inhibits RANKL-induced osteoclastogenesis by regulating NF-κB and JNK signaling pathways. Biomed. Pharmacother., 2018, 100, 142-146. doi: 10.1016/j.biopha.2018.02.014 PMID: 29428661</mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation>Bai, R.; Yin, X.; Feng, X.; Cao, Y.; Wu, Y.; Zhu, Z.; Li, C.; Tu, P.; Chai, X. Corydalis hendersonii Hemsl. protects against myocardial injury by attenuating inflammation and fibrosis via NF-κB and JAK2-STAT3 signaling pathways. J. Ethnopharmacol., 2017, 207, 174-183. doi: 10.1016/j.jep.2017.06.020 PMID: 28629818</mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation>Shi, Q.; Li, T.T.; Wu, Y.M.; Sun, X.Y.; Lei, C.; Li, J.Y.; Hou, A.J. Meroterpenoids with diverse structures and anti-inflammatory activities from Rhododendron anthopogonoides. Phytochemistry, 2020, 180, 112524. doi: 10.1016/j.phytochem.2020.112524 PMID: 33038550</mixed-citation></ref></ref-list></back></article>
